Enjoy complimentary customisation on priority with our Enterprise License!
The tetanus toxoid vaccine market share is expected to increase by USD 1.17 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 4.3%.
This tetanus toxoid vaccine market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. The tetanus toxoid vaccine market report also offers information on several market vendors, including Actiza Pharmaceutical Pvt. Ltd., AJ Vaccines AS, Amson Vaccines and Pharma Pvt Ltd., Avalon Pharma Pvt. Ltd., Bharat Biotech Ltd., CSL Ltd., Dano Vaccines and Biologicals Pvt. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Grifols SA, Incepta Vaccine Ltd., Meiji Holdings Co. Ltd., Merck and Co. Inc., Microgen, Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., and Zoetis Inc. among others.
The tetanus toxoid vaccine market has been broadly categorized into the following demographic segmentations:
Download the Free Report Sample to Unlock the Tetanus Toxoid Vaccine Market Size for the Forecast Period and Other Important Statistics
The licensing agreements is notably driving the tetanus toxoid vaccine market growth, although factors such as the high cost of healthcare may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the tetanus toxoid vaccine industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Tetanus Toxoid Vaccine Market Driver
Key Tetanus Toxoid Vaccine Market Trend
Key Tetanus Toxoid Vaccine Market Challenge
This tetanus toxoid vaccine market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the tetanus toxoid vaccine market encompasses successful business strategies deployed by the key vendors. The tetanus toxoid vaccine market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The tetanus toxoid vaccine market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
39% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for the tetanus toxoid vaccine market in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).
The higher coverage provided to end-users will facilitate the tetanus toxoid vaccine market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the COVID-19 pandemic had a negative impact on the regional tetanus toxoid vaccine market. However, in 2021, due to the availability of COVID-19 vaccines, the number of COVID-19 cases in the region declined. Thus, due to the ease of COVID-related restrictions and access to hospitals and clinics restored, the demand for tetanus toxoid vaccines rebounded. Thus, due to these factors, the regional tetanus toxoid vaccine market will continue to grow during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The tetanus toxoid vaccine market share growth by the neonatals segment will be significant during the forecast period. Neonatal tetanus is a significant cause of neonatal mortality as it has a case-fatality rate of 80%-100%. The disease is more prevalent in rural areas, especially in low-income countries, where deliveries occur at home in an unclean environment and without adequate sterile procedures. However, neonatal tetanus can be prevented through immunization with tetanus toxoid vaccines. Thus, these factors will continue to drive the growth of the global tetanus toxoid vaccine market during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the tetanus toxoid vaccine market size and actionable market insights on post COVID-19 impact on each segment.
Technavio categorizes the global tetanus toxoid vaccine market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the tetanus toxoid vaccine market during the forecast period.
Our report provides extensive information on the value chain analysis for the tetanus toxoid vaccine market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
Tetanus Toxoid Vaccine Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.3% |
Market growth 2022-2026 |
$ 1.17 billion |
Market structure |
Fragmented |
YoY growth (%) |
3.7 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key consumer countries |
US, Canada, Germany, UK, and France |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Actiza Pharmaceutical Pvt. Ltd., AJ Vaccines AS, Amson Vaccines and Pharma Pvt Ltd., Avalon Pharma Pvt. Ltd., Bharat Biotech Ltd., CSL Ltd., Dano Vaccines and Biologicals Pvt. Ltd., Emergent BioSolutions Inc., GlaxoSmithKline Plc, Grifols SA, Incepta Vaccine Ltd., Meiji Holdings Co. Ltd., Merck and Co. Inc., Microgen, Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., and Zoetis Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Age Group
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.